<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>26(5)</volume><submitter>Nishikiori K</submitter><pubmed_abstract>In designing drug dosing for hemodialysis patients, the removal rate (RR) of the drug by hemodialysis is important. However, acquiring the RR is difficult, and there is a need for an estimation method that can be used in clinical settings. In this study, the RR predictive model was constructed using the RR of known drugs by quantitative structure-activity relationship (QSAR) analysis. Drugs were divided into a model construction drug set (75%) and a model validation drug set (25%). The RR was collected from 143 medicines. The objective variable (RR) and chemical structural characteristics (descriptors) of the drug (explanatory variable) were used to construct a prediction model using partial least squares (PLS) regression and artificial neural network (ANN) analyses. The determination coef</pubmed_abstract><journal>Molecular diversity</journal><pagination>2647-2657</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9532302</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Construction of a prediction model for drug removal rate in hemodialysis based on chemical structures.</pubmed_title><pmcid>PMC9532302</pmcid><pubmed_authors>Uesawa Y</pubmed_authors><pubmed_authors>Nishikiori K</pubmed_authors><pubmed_authors>Tanaka K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Construction of a prediction model for drug removal rate in hemodialysis based on chemical structures.</name><description>In designing drug dosing for hemodialysis patients, the removal rate (RR) of the drug by hemodialysis is important. However, acquiring the RR is difficult, and there is a need for an estimation method that can be used in clinical settings. In this study, the RR predictive model was constructed using the RR of known drugs by quantitative structure-activity relationship (QSAR) analysis. Drugs were divided into a model construction drug set (75%) and a model validation drug set (25%). The RR was collected from 143 medicines. The objective variable (RR) and chemical structural characteristics (descriptors) of the drug (explanatory variable) were used to construct a prediction model using partial least squares (PLS) regression and artificial neural network (ANN) analyses. The determination coef</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2026-04-28T03:19:07.543Z</modification><creation>2025-04-04T13:46:29.312Z</creation></dates><accession>S-EPMC9532302</accession><cross_references><pubmed>34973116</pubmed><doi>10.1007/s11030-021-10348-7</doi></cross_references></HashMap>